NO990450D0 - Behandling av sinnslidelser - Google Patents

Behandling av sinnslidelser

Info

Publication number
NO990450D0
NO990450D0 NO990450A NO990450A NO990450D0 NO 990450 D0 NO990450 D0 NO 990450D0 NO 990450 A NO990450 A NO 990450A NO 990450 A NO990450 A NO 990450A NO 990450 D0 NO990450 D0 NO 990450D0
Authority
NO
Norway
Prior art keywords
treatment
mental disorders
disorders
mental
relates
Prior art date
Application number
NO990450A
Other languages
English (en)
Norwegian (no)
Other versions
NO990450L (no
Inventor
Anders Fink-Jensen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO990450L publication Critical patent/NO990450L/no
Publication of NO990450D0 publication Critical patent/NO990450D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO990450A 1996-07-31 1999-01-29 Behandling av sinnslidelser NO990450D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK82496 1996-07-31
PCT/DK1997/000320 WO1998005330A1 (en) 1996-07-31 1997-07-25 Treatment of psychotic disorders

Publications (2)

Publication Number Publication Date
NO990450L NO990450L (no) 1999-01-29
NO990450D0 true NO990450D0 (no) 1999-01-29

Family

ID=8097971

Family Applications (1)

Application Number Title Priority Date Filing Date
NO990450A NO990450D0 (no) 1996-07-31 1999-01-29 Behandling av sinnslidelser

Country Status (18)

Country Link
US (1) US5914333A (de)
EP (1) EP0920316B1 (de)
JP (1) JP2000515156A (de)
KR (1) KR20000029525A (de)
CN (1) CN1226828A (de)
AT (1) ATE330604T1 (de)
AU (1) AU728191B2 (de)
BR (1) BR9710893A (de)
CA (1) CA2260863C (de)
CZ (1) CZ29899A3 (de)
DE (1) DE69736180T2 (de)
ES (1) ES2268732T3 (de)
HU (1) HUP9904030A3 (de)
IL (1) IL128028A0 (de)
NO (1) NO990450D0 (de)
PL (1) PL331321A1 (de)
WO (1) WO1998005330A1 (de)
ZA (1) ZA976854B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5914333A (en) * 1996-07-31 1999-06-22 Novo Nordisk A/S Treatment of psychotic disorders
IE970588A1 (en) 1997-08-01 2000-08-23 Elan Corp Plc Controlled release pharmaceutical compositions containing tiagabine
AU8643698A (en) * 1997-08-01 1999-02-22 Elan Corporation, Plc Controlled release pharmaceutical compositions containing tiagabine
FR2771292B1 (fr) * 1997-11-21 2000-02-18 Ethypharm Lab Prod Ethiques Spheroides contenant de la tiagabine, procede de preparation et compositions pharmaceutiques
US6465458B1 (en) * 1999-07-01 2002-10-15 Pharmacia & Upjohn Company Method of treating or preventing chronic pain with a highly selective norepinephrine reuptake inhibitor
US6270438B1 (en) * 1999-12-22 2001-08-07 Yuan-Cheng Liao Combination driving hub for bicycle
EP1299352B1 (de) 2000-06-30 2005-12-28 Elan Pharmaceuticals, Inc. Verbindungen zur behandlung der alzheimerischen krankheit
US20050070524A1 (en) * 2003-06-06 2005-03-31 Pharmacia Corporation Compositions of a cyclooxygenase-2 selective inhibitor and an anticonvulsant agent for the treatment of central nervous system disorders
US20090139311A1 (en) 2007-10-05 2009-06-04 Applied Biosystems Inc. Biological Analysis Systems, Devices, and Methods

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4383999A (en) * 1981-05-26 1983-05-17 Smithkline Beckman Corporation Inhibition of GABA uptake by N-substituted azaheterocyclic carboxylic acids and their esters
DK288385D0 (da) * 1985-06-26 1985-06-26 Novo Industri As Aminosyrederivater
DK58291D0 (da) * 1991-04-02 1991-04-02 Novo Nordisk As Krystalinsk stof og dets fremstilling
ZA953078B (en) * 1994-04-28 1996-01-05 Alza Corp Effective therapy for epilepsies
US5750140A (en) * 1994-05-20 1998-05-12 Novo Nordisk A/S Transdermal delivery of tiagabine
US5767117A (en) * 1994-11-18 1998-06-16 The General Hospital Corporation Method for treating vascular headaches
MX9708394A (es) * 1995-05-05 1998-02-28 Novo Nordisk As Composicion farmaceutica que contiene clorhidrato de tiagabina y el proceso para su preparacion.
DE19525598C2 (de) * 1995-07-13 1997-09-25 Max Planck Gesellschaft Schlafmittel
UA52661C2 (uk) * 1996-06-14 2003-01-15 Ново Нордіск А/С Безводна кристалічна форма гідрохлориду r(-)-n-(4,4-ди(3-метилтієн-2-іл)бут-3-еніл) ніпекотинової кислоти
US5914333A (en) * 1996-07-31 1999-06-22 Novo Nordisk A/S Treatment of psychotic disorders
DK174041B1 (da) * 1998-11-26 2002-05-06 Monarflex As Gennemføring til montering i en fleksibel membran

Also Published As

Publication number Publication date
AU3619797A (en) 1998-02-25
KR20000029525A (ko) 2000-05-25
DE69736180D1 (de) 2006-08-03
HUP9904030A3 (en) 2000-07-28
EP0920316A1 (de) 1999-06-09
CZ29899A3 (cs) 1999-06-16
HUP9904030A2 (hu) 2000-05-28
NO990450L (no) 1999-01-29
US5914333A (en) 1999-06-22
PL331321A1 (en) 1999-07-05
CA2260863C (en) 2008-02-12
AU728191B2 (en) 2001-01-04
JP2000515156A (ja) 2000-11-14
DE69736180T2 (de) 2007-06-14
CN1226828A (zh) 1999-08-25
WO1998005330A1 (en) 1998-02-12
ZA976854B (en) 1998-03-19
ATE330604T1 (de) 2006-07-15
BR9710893A (pt) 1999-08-17
CA2260863A1 (en) 1998-02-12
IL128028A0 (en) 1999-11-30
ES2268732T3 (es) 2007-03-16
EP0920316B1 (de) 2006-06-21

Similar Documents

Publication Publication Date Title
NO961483D0 (no) Fremgangsmåte for behandling av oljeholdig formasjon
NO965377L (no) Indolinonforbindelser for behandling av sykdommer
NO991955D0 (no) FremgangsmÕte for behandling av hydrokarboner
PT841928E (pt) Formulacao de libertacao prolongada de d-trep-metilfenidato
ES2145915T3 (es) Derivados estereoquimicos de la wortmannina.
DK0811110T3 (da) Oliekildebehandling
NO976063D0 (no) Fremgangsmåte for behandling av diabetes
DE69718731D1 (de) Kombinationstherapie für die Behandlung von Psychosen
UA27911C2 (uk) Засіб для лікування або запобігання фізіологічних розладів, які викликані надлишком тахікініну
NO20005884L (no) Kombinasjonsterapi for behandling av bipolare forstyrrelser
ITTO940748A0 (it) Condotto protesico particolarmente per il trattamento di patologie cardiovascolari.
FI960748A0 (fi) Antipsykoottinen menetelmä
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
NO990450D0 (no) Behandling av sinnslidelser
DE69735417D1 (de) 2,5-dihydroxybenzylsulfonderivate zur behandlung von sexuellen störungen
NO991734D0 (no) Pyrazolinoner for behandling av potensforstyrrelser
ATE230741T1 (de) 3-tetrahydropyridin-4-yl-indole zur behandlung von psychotischen störungen
NO974569L (no) Benzamider for behandling av neurodegenerative forstyrrelser
NO984189D0 (no) Fremgangsmåte for behandling av bipolar forstyrrelse
NO963601D0 (no) Fremgangsmåte for behandling av oljeproduserende systemer
NO986053D0 (no) Antikonvulsive derivater for behandling av psoriasis
TR200003083T2 (tr) CNS hastalıklarının tedavisi için paroxetine 10-camphorsulfonate.
UA25221A (uk) Спосіб лікуваhhя розладів цеhтральhої hервової системи
NO307416B1 (no) Fremgangsmåte for desinfisering av avløpsvann
NO996166D0 (no) Fremgangsmåte for behandling av avluter

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application